Results 21 to 30 of about 25,093 (162)

Prevalence and Molecular Characteristics Based on Whole Genome Sequencing of Mycobacterium tuberculosis Resistant to Four Anti-Tuberculosis Drugs from Southern Xinjiang, China

Infection and Drug Resistance, 2021
Aiketaguli Anwaierjiang,1,* Quan Wang,2,* Haican Liu,3,* Chunjie Yin,1 Miao Xu,2 Machao Li,3 Mengwen Liu,1 Yan Liu,2 Xiuqin Zhao,3 Jinbao Liu,1 Guilian Li,3 Xiaokaiti Mijiti,2 Kanglin Wan3 1College of Public Health, Xinjiang Medical ...
Anwaierjiang A, Wang Q, Liu H, Yin C, Xu M, Li M, Liu M, Liu Y, Zhao X, Liu J, Li G, Mijiti X, Wan K   +12 more
doaj  

Ethambutol-induced optic neuropathy

Biomedical Papers, 2023
Purpose. A case report of a 40-year-old patient with tuberculosis treated with ethambutol is described. Within six months of starting treatment, there was a painless sudden decline in visual function.
Martin Kyncl, Martin Fus, Jan Lestak
doaj   +1 more source

Clinical Manifestations and Outcomes of Tubercular Uveitis in Taiwan—A Ten-Year Multicenter Retrospective Study

Medicina, 2022
Background andObjectives: This 10-year multicenter retrospective study reviewed the clinical manifestations, diagnostic tests, and treatment modalities of tubercular uveitis (TBU), including direct infection and indirect immune-mediated hypersensitivity ...
Chun-Ju Lin, Ning-Yi Hsia, De-Kuang Hwang, Yih-Shiou Hwang, Yo-Chen Chang, Yueh-Chang Lee, Yung-Ray Hsu, Po-Ting Yeh, Chang-Ping Lin, Hsi-Fu Chen, Wei-Chun Jan, Wei-Yu Chiang, Ming-Ling Tsai   +12 more
doaj   +1 more source

Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease

BMC Pulmonary Medicine, 2019
Background A three-drug regimen (macrolide, ethambutol, and rifampicin) is recommended for the treatment of Mycobacterium avium complex pulmonary disease (MAC-PD).
Hyung-Jun Kim, Jong Sik Lee, Nakwon Kwak, Jaeyoung Cho, Chang-Hoon Lee, Sung Koo Han, Jae-Joon Yim   +6 more
doaj   +1 more source

Frequency of mutational changes in the embB among the ethambutol-resistant strains of Mycobacterium tuberculosis in Iran

Journal of Infection in Developing Countries, 2016
Introduction: Early detection of drug resistant tuberculosis is one of the main priorities of TB control program. Ethambutol (EMB) is a first-line anti-TB drug that is effective for preventing treatment failures caused by Mycobacterium tuberculosis ...
Faranak Rezaei, Mehri Haeili, Parviz Mohajeri, Abdolrazagh Hashemi Shahraki, Abbas Ali Imani Fooladi, Fatemeh Zahednamazi, Mohammad Mehdi Feizabadi   +6 more
doaj   +1 more source

Analysis of Isoniazid, Streptomycin and Ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco

Journal of Infection in Developing Countries, 2009
Background: Drug-resistant tuberculosis is a major problem worldwide. Based on the knowledge of specific mutations occurring in Mycobacterium tuberculosis genome, drug resistance can be detected earlier.
Imane Chaoui, Radia Sabouni, Moussa Kourout, Annemie M. Jordaan, Ouafae Lahlou, Rajae Elouad, Mohammed Akrim, Thomas C. Victor, Mohammed Elmzibri   +8 more
doaj   +1 more source

Ethambutol in tuberculosis

Biomedicine & Pharmacotherapy, 1990
Ethambutol gained rapid acceptance as a substitute for PAS in tuberculosis therapy because of improved patient tolerance and convenience of administration. Ocular toxicity was recognized early on but was thought to be a problem only at higher dosages.
openaire   +2 more sources

Current and emerging treatment strategies for Mycobacterium avium complex pulmonary disease: a narrative review [PDF]

The Ewha Medical Journal
The Mycobacterium avium complex (MAC), comprising M. avium and M. intracellulare, constitutes the predominant cause of nontuberculous mycobacterial pulmonary disease (NTM-PD) in Korea, followed by the M. abscessus complex.
Chiwook Chung
doaj   +1 more source

Correlations among the plasma concentrations of first-line anti-tuberculosis drugs and the physiological parameters influencing concentrations

Frontiers in Pharmacology, 2023
Background: The plasma concentrations of the four most commonly used first-line anti-tuberculosis (TB) drugs, isoniazid (INH), rifampicin (RMP), ethambutol (EMB), and pyrazinamide (PZA), are often not within the therapeutic range.
Lin Cheng, Ming Luo, Yan Guo, Yunfan Fan, Pengsen Wang, Gang Zhou, Shiwei Qin, Bangbi Weng, Peibo Li, Zhirui Liu, Songtao Liu   +10 more
doaj   +1 more source

Is Dosing of Ethambutol as Part of a Fixed-Dose Combination Product Optimal for Mechanically Ventilated ICU Patients with Tuberculosis? A Population Pharmacokinetic Study

Antibiotics, 2021
Background: Tuberculosis (TB) patients admitted to intensive care units (ICU) have high mortality rates. It is uncertain whether the pharmacokinetics of first-line TB drugs in ICU patients are different from outpatients.
Francisco Beraldi-Magalhaes, Suzanne L. Parker, Cristina Sanches, Leandro Sousa Garcia, Brenda Karoline Souza Carvalho, Mariana Millan Fachi, Marcus Vinicius de Liz, Roberto Pontarolo, Jeffrey Lipman, Marcelo Cordeiro-Santos, Jason A. Roberts   +10 more
doaj   +1 more source